FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

OCAMPO RAYMOND L JR

2. Date of Event Requiring Statement (MM/DD/YYYY)
7/15/2010 

3. Issuer Name and Ticker or Trading Symbol

ACTUATE CORP [ACTU]

(Last)        (First)        (Middle)

2207 BRIDGEPOINTE PARKWAY, SUITE 500

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            _____ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

SAN MATEO, CA 94404       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   (1) (2) 12500   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)   7/15/2011   (3) 7/15/2020   Common Stock   25000   $0   D    

Explanation of Responses:
( 1)  Represents shares of the Issuer's common stock underlying restricted stock units ("RSUs") awarded to the Reporting Person. The RSUs will vest in a series of four successive equal annual installments, with the first installment to vest on August 15, 2011 and the remaining installments to vest on the second, third and fourth anniversaries of the July 15, 2010 award date, provided the Reporting Person remains a director through such date, subject to accelerated vesting upon the Reporting Person's termination of directorship under certain prescribed circumstances within 12 months following certain changes in
( 2)  ownership or control of the Issuer or during the period commencing with the Issuer's execution of a definitive agreement to effect a change in control and ending on the earlier to occur of (i) the closing of the change in control transaction or (ii) the termination of such definitive agreement. Unless the Reporting Person elects to defer the issuance of the shares until the Reporting Person's separation of service from the Issuer, the shares of the Issuer's common stock will be issued as the RSU's vest.
( 3)  Option becomes exercisable as to 1/4 of the option shares after one year from the vesting commencement date of July 15, 2010 and for the balance in a series of equal monthly installments over the following 36 month

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
OCAMPO RAYMOND L JR
2207 BRIDGEPOINTE PARKWAY, SUITE 500
SAN MATEO, CA 94404
X



Signatures
/s/ Raymond L. Ocampo Jr. 7/20/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Grafico Azioni Actuate Therapeutics (NASDAQ:ACTU)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Actuate Therapeutics
Grafico Azioni Actuate Therapeutics (NASDAQ:ACTU)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Actuate Therapeutics